BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
ERBB2
,
calcium channel activity
,
HIV infection
,
Hypothalamus
,
Avian flu virus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Tamoxifen
NextBio Summary
General Info
Curated Studies
Most Correlated Studies
Identification of biomarkers distinguishing chemical contaminants using rat hepatocytes
Genomics Assisted Toxicity Evaluation system study - Human Hepatocytes
Genomics Assisted Toxicity Evaluation system study - Rat Liver Single Dose
Genomics Assisted Toxicity Evaluation system study - Rat Liver Repeat Doses
Genomics Assisted Toxicity Evaluation system study - Rat Hepatocytes
Explore Curated Studies Results
Literature
Most Relevant Literature
CIP2A expression predicts recurrences of tamoxifen-treated breast cancer.
Tamoxifen-induced radiation recall dermatitis.
Tamoxifen Pharmacovigilance: Implications for Safe Use in the Future.
Refractory Tamoxifen-Induced Keratopathy Despite Drug Withdrawal.
Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Treatment With Tamoxifen in Cryptococcal Meningitis
Tamoxifen to Treat Barrett's Metaplasia
Tamoxifen in Patients With Oesophageal Cancer
Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension
Tamoxifen Pharmacogenetics and Clinical Effects
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ